U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C11H13BrN2O3
Molecular Weight 301.1365
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2C-B-AMINOREX

SMILES

COc1cc(c(cc1C2CNC(=N)O2)OC)Br

InChI

InChIKey=XUTCHZHTIDHQOP-UHFFFAOYSA-N
InChI=1S/C11H13BrN2O3/c1-15-8-4-7(12)9(16-2)3-6(8)10-5-14-11(13)17-10/h3-4,10H,5H2,1-2H3,(H2,13,14)

HIDE SMILES / InChI

Molecular Formula C11H13BrN2O3
Molecular Weight 301.1365
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

Substance Class Chemical
Created
by admin
on Fri Jun 25 23:53:26 UTC 2021
Edited
by admin
on Fri Jun 25 23:53:26 UTC 2021
Record UNII
HBY9BQ3YJK
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
2C-B-AMINOREX
Common Name English
5-(2,5-DIMETHOXY-4-BROMOPHENYL)-4,5-DIHYDRO-1,3-OXAZOL-2-AMINE
Systematic Name English
2C-B AMINOREX
Common Name English
Code System Code Type Description
FDA UNII
HBY9BQ3YJK
Created by admin on Fri Jun 25 23:53:26 UTC 2021 , Edited by admin on Fri Jun 25 23:53:26 UTC 2021
PRIMARY
Related Record Type Details
TRANSPORTER -> SUBSTRATE
Our data show that drugs known or suspected to increase the risk of PPH (eg, aminorex, fenfluramine, and chlorphentermine) are 5-HT transporter substrates, whereas drugs that have not been shown to increase the risk of PPH are less potent in this regard.